134 related articles for article (PubMed ID: 1839654)
1. Immunogenicity and protective efficacy of low dose recombinant DNA hepatitis B vaccine in normal and high-risk neonates.
Assateerawatt A; Tanphaichitr VS; Suvatte V; In-ngarm L
Asian Pac J Allergy Immunol; 1991 Dec; 9(2):89-93. PubMed ID: 1839654
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B immunization in high risk neonates born from HBsAg positive mothers: comparison between plasma derived and recombinant DNA vaccine.
Pongpipat D; Suvatte V; Assateerawatts A
Asian Pac J Allergy Immunol; 1989 Jun; 7(1):37-40. PubMed ID: 2526633
[TBL] [Abstract][Full Text] [Related]
3. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
Gunn TR; Bosley A; Woodfield DG
N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
[TBL] [Abstract][Full Text] [Related]
4. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers.
Lee CY; Huang LM; Chang MH; Hsu CY; Wu SJ; Sung JL; Safary A
Pediatr Infect Dis J; 1991 Apr; 10(4):299-303. PubMed ID: 1829515
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
[TBL] [Abstract][Full Text] [Related]
6. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
[TBL] [Abstract][Full Text] [Related]
7. [Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2].
Tron F; Soulié JC; Goudeau A; Devillier P; Saliou P
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):901-5. PubMed ID: 1840243
[TBL] [Abstract][Full Text] [Related]
8. Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage.
Poovorawan Y; Sanpavat S; Pongpunlert W; Chumdermpadetsuk S; Sentrakul P; Chitinand S; Sakulramrung R; Tannirundorn Y
Vaccine; 1990 Mar; 8 Suppl():S56-9; discussion S60-2. PubMed ID: 2139286
[TBL] [Abstract][Full Text] [Related]
9. Prevention of hepatitis B infection in infants born to hepatitis B carrier mothers: low dosage vaccination.
Theppisai U; Thanuntaseth C; Chiewsilp P; Siripoonya P
Int J Gynaecol Obstet; 1990 Aug; 32(4):353-7. PubMed ID: 1977630
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
[TBL] [Abstract][Full Text] [Related]
11. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers.
Lo KJ; Tsai YT; Lee SD; Wu TC; Wang JY; Chen GH; Yeh CL; Chiang BN; Yeh SH; Goudeau A
J Infect Dis; 1985 Oct; 152(4):817-22. PubMed ID: 2931490
[TBL] [Abstract][Full Text] [Related]
12. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure.
Lin HH; Chang MH; Chen DS; Sung JL; Hong KH; Young YC; Yang KH; Lee TY
Vaccine; 1991 Jun; 9(6):457-60. PubMed ID: 1832257
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of the immunogenicity of yeast-derived (recombinant) and plasma-derived hepatitis B vaccine in infants.
Panda SK; Ramesh R; Rao KV; Gupta A; Zuckerman AJ; Nayak NC
J Med Virol; 1991 Dec; 35(4):297-302. PubMed ID: 1802958
[TBL] [Abstract][Full Text] [Related]
14. Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers.
Belloni C; Orsolini P; Soldini L; Campisi D; Chiesa A; Ciceri R; Filice G
Microbiologica; 1991 Jul; 14(3):195-8. PubMed ID: 1833611
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients.
Fujiyama S; Yoshida K; Sato T; Shimada H; Deguchi T
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():140-4. PubMed ID: 2150664
[TBL] [Abstract][Full Text] [Related]
16. [Immune response to hepatitis B vaccine in neonates born to mothers with various infection status of hepatitis B virus].
Yin SR
Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Aug; 10(4):198-202. PubMed ID: 2805044
[TBL] [Abstract][Full Text] [Related]
17. Mass protection program of perinatal hepatitis B virus infection in Japan and impact of an optional booster vaccination on its efficacy.
Tajiri H; Kozaiwa K; Harada T; Ozaki Y; Miki K; Shimizu K; Okada S
Acta Paediatr Jpn; 1991 Jun; 33(3):323-6. PubMed ID: 1785327
[TBL] [Abstract][Full Text] [Related]
18. Prevention of vertical transmission of hepatitis B virus by yeast recombinant hepatitis B vaccine.
Murata R; Isshiki G; Yoshioka H; Chiba Y; Tada H; Koike M; Kimura M
Acta Paediatr Jpn; 1989 Apr; 31(2):180-5. PubMed ID: 2516698
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers.
Poovorawan Y; Sanpavat S; Pongpunlert W; Chumdermpadetsuk S; Sentrakul P; Safary A
JAMA; 1989 Jun; 261(22):3278-81. PubMed ID: 2523981
[TBL] [Abstract][Full Text] [Related]
20. Immune response to hepatitis B vaccine in premature neonates.
Chawareewong S; Jirapongsa A; Lokaphadhana K
Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):39-40. PubMed ID: 1835140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
